Travere Therapeutics

ADMA Biologics

Alnylam Pharmaceuticals

TG Therapeutics

Exelixis

Mirum Pharmaceuticals Inc

Aurinia Pharmaceuticals

Phathom Pharmaceuticals

Gilead Sciences

Rhythm Pharmaceuticals

Virtus LifeSci Biotech Products ETF

BBP tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider.

First Trust NYSE Arca Biotechnology Index Fund

iShares Nasdaq Biotechnology ETF

ALPS Medical Breakthroughs ETF

While the rest of the biotechnology sector remained depressed along with the broader markets, related exchange traded funds found strength from an unexpected surge in ACADIA Pharmaceuticals (NasdaqGS: ACAD), following the biopharma company’s positive announcement for a phase 3 trail on dementia-related psychosis.

ACADIA Pharmaceuticals Help Lift Biotech ETFs

ARK Genomic Revolution Multi-Sector ETF

Principal Healthcare Innovators Index ETF

SPDR S&P Biotech ETF

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.

Biotechnology Market on a Tear: 5 ETFs in Spotlight

Xtrackers Harvest CSI 300 China A-Shares ETF

Xtrackers MSCI China A Inclusion Equity ETF

KraneShares Bosera MSCI China A Share ETF

Invesco Golden Dragon China ETF

Invesco DWA Technology Momentum ETF

PowerShares Russell Midcap Pure Growth Portfolio

SPDR S&P Software & Services ETF

We are presenting a bunch of top performing ETFs of the first quarter with a solid Zacks ETF Rank #1 or 2 which are expected to outperform in the quarter ahead.

A Spread of Top-Ranked ETFs That Crushed the Market in Q1

News for Virtus LifeSci Biotech Products ETF ETF (BBP)